aspirin

Aspirin: Science and Development

Introduction to Aspirin

  • Aspirin is derived from willow bark, historically used as a folk remedy.

  • First synthesized in 1899; contains acetylsalicylic acid.

  • Extremely popular: over 80 million tablets consumed daily in the U.S.

  • Therapeutic effects include pain relief, reduction of inflammation, and prevention of heart attacks.

Actions of Aspirin

  • Pain and Inflammation: Aspirin alleviates pain and inflammation by inhibiting enzyme COX, which is responsible for producing prostaglandins that cause these symptoms.

  • Heart Attack Prevention: Low-dose aspirin (under 100mg) helps prevent blood clots, thus reducing the risk of heart attacks and strokes.

  • Stomach Upset: Side effects include gastrointestinal irritation, ulcers, and internal bleeding due to inhibition of COX1, which protects the stomach lining.

Types of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

  • Aspirin's relatives include ibuprofen (Advil, Motrin) and naproxen (Aleve).

  • Super Aspirins: Celebrex and Vioxx, developed in the late 20th century, selectively inhibit COX2 for anti-inflammatory effects with fewer stomach side effects.

Research and Discovery Approach

  • Various methodologies employed: trial and error, laboratory experiments, clinical tests, and rational drug design.

  • Progress from folk remedies to scientific validation of aspirin's effects by focused research.

Chemical Background

  • Acetylsalicylic acid is a derivative of salicylic acid.

  • Historical medicinal usage documented since Egyptian times.

  • Modern aspirin developed through systematic studies starting in the 1760s.

Pharmacological Advances

  • Salicin isolated from willow bark in 1828; lead to identification of salicylic acid as an active ingredient.

  • Pharmacological research advances due to chemical isolation and analysis led to more effective drug formulations.

Impact of Industrial Research

  • Growth of modern pharmaceutical industry influenced by dyes industry innovations.

  • Bayer's strategies in research, development, and marketing established a model for the drug industry.

Discovery of Mechanisms

  • John Vane's Nobel Prize-winning work in 1971 linked the understanding of aspirin's action to COX enzyme inhibition.

  • COX1 and COX2 enzymes have different physiological roles, leading to both therapeutic effects and side effects.

Rational Drug Design

  • Move from empirical approaches to targeted drug design based on scientific understanding of COX mechanisms.

  • The introduction of COX2 inhibitors aimed to maintain therapeutic benefits while minimizing side effects.

Safety and Efficacy Concerns

  • Initial optimism for COX2 inhibitors diminished when safety issues arose, notably with Vioxx, leading to market withdrawal.

  • Ongoing research connects aspirin's action with risks of bleeding and heart health, illustrating the complexity of drug interactions within the body.

Conclusion

  • Aspirin's journey reflects the evolution of science from folk medicine to modern pharmacology, embodying a blend of empirical knowledge and conceptual understanding.

  • Continuous research is essential to uncover deeper pharmacological insights and address safety concerns.